{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T17:13:42Z","timestamp":1778606022699,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Complementary Therapies in Clinical Practice"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.ctcp.2022.101612","type":"journal-article","created":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T21:26:47Z","timestamp":1654032407000},"page":"101612","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Characterizing anxiety, pain, sleep, and quality of life among patients in a state Medical Marijuana Program"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4664-009X","authenticated-orcid":false,"given":"Rebecca L.","family":"Ashare","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily R.","family":"Hajjar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swechhya","family":"Pant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5866-8279","authenticated-orcid":false,"given":"Salimah H.","family":"Meghani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6687-1760","authenticated-orcid":false,"given":"Brooke","family":"Worster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctcp.2022.101612_bib2","series-title":"Medical Marijuana Act.- Enactment","year":"2016"},{"key":"10.1016\/j.ctcp.2022.101612_bib4","unstructured":"CHAPTER 1211. CLINCIAL REGISTRANTS and ACADEMIC CLINICAL RESEARCH CENTERS\u2014TEMPORARY REGULATIONS. Sect. 1211."},{"issue":"9","key":"10.1016\/j.ctcp.2022.101612_bib5","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1002\/cncr.32732","article-title":"Medical cannabis use among individuals with cancer: an unresolved and timely issue","volume":"126","author":"Nugent","year":"2020","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ctcp.2022.101612_bib6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1089\/can.2016.0007","article-title":"A cross-sectional survey of medical cannabis users: patterns of use and perceived efficacy","volume":"1","author":"Sexton","year":"2016","journal-title":"Cannabis and cannabinoid res."},{"key":"10.1016\/j.ctcp.2022.101612_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.626853","article-title":"Evaluation of patient reported safety and efficacy of cannabis from a survey of medical cannabis patients in Canada","volume":"9","author":"Cahill","year":"2021","journal-title":"Front. Public Health"},{"issue":"1","key":"10.1016\/j.ctcp.2022.101612_bib8","first-page":"13","article-title":"Demographics, perceptions, and use of medical marijuana among patients in Florida","volume":"4","author":"Rosenthal","year":"2021","journal-title":"Med. Cannabis Cannab."},{"key":"10.1016\/j.ctcp.2022.101612_bib9","article-title":"Characteristics of adults with a medical cannabis license, reasons for use, and perceptions of benefit following medical cannabis legalization in Oklahoma","volume":"27","author":"Kendzor","year":"2022","journal-title":"Prev. Med. Rep."},{"key":"10.1016\/j.ctcp.2022.101612_bib10","doi-asserted-by":"crossref","DOI":"10.1007\/s00213-021-06047-8","article-title":"Prevalence and self-reported reasons of cannabis use for medical purposes in USA and Canada","author":"Leung","year":"2022","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.ctcp.2022.101612_bib11","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/01.MIB.0000440982.79036.d6","article-title":"Cannabis use provides symptom relief in patients with inflammatory bowel disease but is associated with worse disease prognosis in patients with Crohn's disease","volume":"20","author":"Storr","year":"2014","journal-title":"Inflamm. Bowel Dis."},{"issue":"6290","key":"10.1016\/j.ctcp.2022.101612_bib12","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1126\/science.aaf7450","article-title":"Federal barriers to Cannabis research","volume":"352","author":"Stith","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.ctcp.2022.101612_bib13","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.drugalcdep.2016.12.030","article-title":"The impact of cannabis and cannabinoids for medical conditions on health-related quality of life: a systematic review and meta-analysis","volume":"174","author":"Goldenberg","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.ctcp.2022.101612_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2017.03.009","article-title":"Prevalence, reasons, perceived effects, and correlates of medical marijuana use: a review","volume":"177","author":"Park","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.ctcp.2022.101612_bib15","doi-asserted-by":"crossref","first-page":"101777","DOI":"10.1016\/j.pmedr.2022.101777","article-title":"Characteristics of adults with a medical cannabis license, reasons for use, and perceptions of benefit following medical cannabis legalization in Oklahoma","volume":"27","author":"Kendzor","year":"2022","journal-title":"Preven. med. rep."},{"issue":"2","key":"10.1016\/j.ctcp.2022.101612_bib16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1377\/hlthaff.2018.05266","article-title":"Qualifying conditions of medical cannabis license holders in the United States","volume":"38","author":"Boehnke","year":"2019","journal-title":"Health Aff."},{"key":"10.1016\/j.ctcp.2022.101612_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.addbeh.2020.106752","article-title":"High prevalence of co-occurring substance use in individuals with opioid use disorder","volume":"114","author":"Mahoney","year":"2021","journal-title":"Addict. Behav."},{"key":"10.1016\/j.ctcp.2022.101612_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.827849","article-title":"Adherence, safety, and effectiveness of medical cannabis and epidemiological characteristics of the patient population: a prospective study","volume":"9","author":"Bar-Lev Schleider","year":"2022","journal-title":"Front. Med."},{"issue":"1","key":"10.1016\/j.ctcp.2022.101612_bib19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jpainsymman.2007.12.015","article-title":"Reliability and validity of the functional assessment of chronic illness therapy-palliative care (FACIT-Pal) scale","volume":"37","author":"Lyons","year":"2009","journal-title":"J. Pain Symptom Manag."},{"key":"10.1016\/j.ctcp.2022.101612_bib20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1477-7525-1-79","article-title":"The functional assessment of chronic illness Therapy (FACIT) measurement system: properties, applications, and interpretation","volume":"1","author":"Webster","year":"2003","journal-title":"Health Qual. Life Outcome"},{"issue":"2","key":"10.1016\/j.ctcp.2022.101612_bib21","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1177\/0163278705275341","article-title":"General population and cancer patient norms for the functional assessment of cancer therapy-general (FACT-G)","volume":"28","author":"Brucker","year":"2005","journal-title":"Eval. Health Prof."},{"issue":"6","key":"10.1016\/j.ctcp.2022.101612_bib22","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/pon.1428","article-title":"The queensland cancer risk study: general population norms for the functional assessment of cancer therapy-general (FACT-G)","volume":"18","author":"Janda","year":"2009","journal-title":"Psycho Oncol."},{"issue":"2","key":"10.1016\/j.ctcp.2022.101612_bib23","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1177\/0163278705275340","article-title":"Combining distribution- and anchor-based approaches to determine minimally important differences: the FACIT experience","volume":"28","author":"Yost","year":"2005","journal-title":"Eval. Health Prof."},{"key":"10.1016\/j.ctcp.2022.101612_bib25","series-title":"Pennsylvania Department of Health's Office of Medical Marijuana Two-Year Report - May 15","year":"2020"},{"key":"10.1016\/j.ctcp.2022.101612_bib26","series-title":"Engineering, and Medicine. The Health Effects of Cannabis and Cannabinoids","year":"2017"},{"issue":"12","key":"10.1016\/j.ctcp.2022.101612_bib27","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S2215-0366(19)30401-8","article-title":"Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis","volume":"6","author":"Black","year":"2019","journal-title":"Lancet Psychiatr."},{"issue":"4","key":"10.1016\/j.ctcp.2022.101612_bib28","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.17r11839","article-title":"Association of cannabis with long-term clinical symptoms in anxiety and mood disorders: a systematic review of prospective studies","volume":"79","author":"Mammen","year":"2018","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.ctcp.2022.101612_bib29","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.socscimed.2019.06.005","article-title":"Patient-reported use of medical cannabis for pain, anxiety, and depression symptoms: systematic review and meta-analysis","volume":"233","author":"Kosiba","year":"2019","journal-title":"Soc. Sci. Med."},{"issue":"1","key":"10.1016\/j.ctcp.2022.101612_bib30","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3109\/00952990.2013.821477","article-title":"Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users","volume":"40","author":"Bonn-Miller","year":"2014","journal-title":"Am. J. Drug Alcohol Abuse"},{"issue":"4","key":"10.1016\/j.ctcp.2022.101612_bib31","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/02791072.2015.1074766","article-title":"Medical cannabis in Arizona: patient characteristics, perceptions, and impressions of medical cannabis legalization","volume":"47","author":"Troutt","year":"2015","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.ctcp.2022.101612_bib32","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jad.2020.05.132","article-title":"Short and long-term effects of cannabis on symptoms of post-traumatic stress disorder","volume":"274","author":"LaFrance","year":"2020","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.ctcp.2022.101612_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0246990","article-title":"The short-term impact of 3 smoked cannabis preparations versus placebo on PTSD symptoms: a randomized cross-over clinical trial","volume":"16","author":"Bonn-Miller","year":"2021","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.ctcp.2022.101612_bib34","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1177\/1049909112454215","article-title":"Prospectively surveying health-related quality of life and symptom relief in a lot-based sample of medical cannabis-using patients in urban Washington State reveals managed chronic illness and debility","volume":"30","author":"Aggarwal","year":"2013","journal-title":"Am. j. hosp. palliat. care"},{"issue":"2","key":"10.1016\/j.ctcp.2022.101612_bib35","first-page":"1181","article-title":"Cannabis use among Danish patients with cancer: a cross-sectional survey of sociodemographic traits, quality of life, and patient experiences","volume":"30","author":"Nielsen","year":"2022","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.ctcp.2022.101612_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2019.102657","article-title":"The relationships between chronic pain and changes in health with cannabis consumption patterns","volume":"76","author":"Cooke","year":"2020","journal-title":"Int. J. Drug Pol."},{"issue":"1","key":"10.1016\/j.ctcp.2022.101612_bib37","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/ajad.12963","article-title":"Cannabis and cannabinoids in mood and anxiety disorders: impact on illness onset and course, and assessment of therapeutic potential","volume":"29","author":"Botsford","year":"2020","journal-title":"Am. J. Addict."},{"issue":"1","key":"10.1016\/j.ctcp.2022.101612_bib38","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1186\/s12889-021-10867-w","article-title":"Opioid use in medical cannabis authorization adult patients from 2013 to 2018: alberta, Canada","volume":"21","author":"Lee","year":"2021","journal-title":"BMC Publ. Health"},{"issue":"3","key":"10.1016\/j.ctcp.2022.101612_bib39","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jpainsymman.2019.10.029","article-title":"When patients take charge of opioids: self-management concerns and practices among cancer outpatients in the context of opioid crisis","volume":"59","author":"Meghani","year":"2020","journal-title":"J. Pain Symptom Manag."},{"key":"10.1016\/j.ctcp.2022.101612_bib40","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.drugpo.2017.01.011","article-title":"Medical cannabis access, use, and substitution for prescription opioids and other substances: a survey of authorized medical cannabis patients","volume":"42","author":"Lucas","year":"2017","journal-title":"Int. J. Drug Pol."},{"issue":"7","key":"10.1016\/j.ctcp.2022.101612_bib41","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-047717","article-title":"Opioid-sparing effects of medical cannabis or cannabinoids for chronic pain: a systematic review and meta-analysis of randomised and observational studies","volume":"11","author":"Noori","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.ctcp.2022.101612_bib42","series-title":"Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research","year":"2011"},{"issue":"12","key":"10.1016\/j.ctcp.2022.101612_bib43","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.jpain.2009.10.002","article-title":"Racial and ethnic disparities in pain: causes and consequences of unequal care","volume":"10","author":"Anderson","year":"2009","journal-title":"J. Pain"},{"issue":"6","key":"10.1016\/j.ctcp.2022.101612_bib44","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1089\/jpm.2006.9.1454","article-title":"Pain and ethnicity in the United States: a systematic review","volume":"9","author":"Cintron","year":"2006","journal-title":"J. Palliat. Med."},{"key":"10.1016\/j.ctcp.2022.101612_bib45","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.drugalcdep.2015.02.009","article-title":"Perceived risk of regular cannabis use in the United States from 2002 to 2012: differences by sex, age, and race\/ethnicity","volume":"149","author":"Pacek","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.ctcp.2022.101612_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2019.102658","article-title":"Prevalence and forms of cannabis use in legal vs. illegal recreational cannabis markets","volume":"76","author":"Goodman","year":"2020","journal-title":"Int. J. Drug Pol."},{"issue":"11","key":"10.1016\/j.ctcp.2022.101612_bib47","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.jpain.2019.05.009","article-title":"Cannabis use preferences and decision-making among a cross-sectional cohort of medical cannabis patients with chronic pain","volume":"20","author":"Boehnke","year":"2019","journal-title":"J. Pain : off. j. Am. Pain Soc."},{"key":"10.1016\/j.ctcp.2022.101612_bib48","article-title":"Differences in cannabis use characteristics, routines, and reasons for use among individuals with and without a medical cannabis card","author":"Berey","year":"2022","journal-title":"Exp. Clin. Psychopharmacol"}],"container-title":["Complementary Therapies in Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1744388122000809?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1744388122000809?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:52:54Z","timestamp":1761677574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1744388122000809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":45,"alternative-id":["S1744388122000809"],"URL":"https:\/\/doi.org\/10.1016\/j.ctcp.2022.101612","relation":{},"ISSN":["1744-3881"],"issn-type":[{"value":"1744-3881","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterizing anxiety, pain, sleep, and quality of life among patients in a state Medical Marijuana Program","name":"articletitle","label":"Article Title"},{"value":"Complementary Therapies in Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctcp.2022.101612","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101612"}}